Granted Patent B2

US 12,564,616 · App. 18/641,028 · Granted Mar 3, 2026

Inventor: Sol Gersh (Bal Harbour, FL)

A61K38/06A61K36/534A61P11/02

Abstract

Claims (23)

1 . A formulation for treatment of respiratory diseases and providing relief in the symptoms of respiratory diseases, the formulation comprising:

a composition comprising, by volume percent thereof:

reduced glutathione 50-80.45%;

Mentha oil 0.2-4%;

pyrroloquinoline quinone 10-30%;

wintergreen oil 0.2-4%;

sodium nitrate 0.1-0.5%; and

oxymetazoline hydrochloride 0.01-0.10%; and

an amount of excipients.

2 . A nasal dosage form for treatment and relief of respiratory diseases, the nasal dosage form comprising:

a composition comprising, by volume percent thereof:

reduced glutathione 50-80.45%;

Mentha oil 0.2-4%;

pyrroloquinoline quinone 10-30%;

wintergreen oil 0.2-4%;

sodium nitrate 0.1-0.5%; and

oxymetazoline hydrochloride 0.01-0.10%; and

an amount of excipients.

3 . A method for treatment and providing relief in respiratory diseases, the method comprising the steps of:

providing a formulation comprising a composition and excipients, wherein the composition comprises reduced glutathione, Mentha oil, pyrroloquinoline quinone, wintergreen oil, sodium nitrate, and oxymetazoline hydrochloride; and

administering the formulation composition through a nasal route, wherein, by volume percent of the composition, the reduced glutathione is present in an amount ranging from 50-89.49%; the Mentha oil is present in an amount ranging from 0.2-4%; the pyrroloquinoline quinone is present in an amount ranging from 10-30%; the wintergreen oil is present in an amount ranging from 0.2-4%; the sodium nitrate is present in an amount ranging from 0.1-0.5%; and the oxymetazoline hydrochloride is present in an amount ranging from 0.01-0.10%.

4 . The method according to claim 3 , wherein the respiratory diseases is a viral infection.

5 . The method of claim 3 , wherein the composition comprises reduced glutathione (GSH) 80.45%, Mentha oil 0.6%, pyrroloquinoline quinone (PQQ) 18%, wintergreen oil 0.6%, sodium nitrate 0.3%, and oxymetazoline hydrochloride 0.05%.

Continuity (2)

References Cited (9)